TickerFacts.

Company research / LIANY

LianBio (LIANY)

Build a valuation ↗↓ Download CSV

CIK 0001831283 · OTC · Pharmaceutical Preparations

  • Sector Manufacturing
  • Fiscal year ends Dec 31

Not updated since 2022-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Key ratios (year ended 2022-12-31)

-42.4%
Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form SC 13G (ownership disclosure) · 2024-11-14

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended2022-12-312021-12-312020-12-31
R&D Expense$59.76M$158.69M$120.89M
Operating Income-$125.35M-$195.57M-$134.87M
Net Income-$110.29M-$196.30M-$139.60M
EPS (Diluted)-$1.02-$5.71-$11.58
Total Assets$319.96M$426.34M$279.29M
Total Liabilities$26.31M$39.01M$27.57M
Shareholders' Equity$259.87M$353.56M-$132.84M
Cash & Equivalents$79.22M$228.18M$254.35M
Operating Cash Flow-$99.19M-$163.95M-$98.14M
Capital Expenditures$1.84M$947.0K$886.0K
Free Cash Flow-$101.03M-$164.90M-$99.03M
Shares Outstanding107.04M107.28M20.48M
Weighted Average Diluted Shares107.92M34.39M12.05M
EPS (Basic)-$1.02-$5.71-$11.58